Today: 11 June 2026
B2PRIME plugs into TradingView, lands ‘platinum’ badge as B2TRADER trading goes chart-side
8 January 2026
1 min read

B2PRIME plugs into TradingView, lands ‘platinum’ badge as B2TRADER trading goes chart-side

LIMASSOL, Cyprus, Jan 8, 2026, 17:00 (GMT+2)

  • B2PRIME said it has integrated its B2TRADER platform with TradingView and was named a Platinum Partner.
  • The firm said clients can trade from TradingView charts and switch between B2TRADER accounts via TradingView’s trading panel.
  • B2PRIME said TradingView serves more than 100 million users worldwide.

B2PRIME Group said on Thursday it has integrated its B2TRADER execution platform with TradingView, letting clients place trades directly from TradingView charts. The company said TradingView has recognised it as a Platinum Partner.

The timing is not random. Charting tools are being pulled deeper into execution, with brokers and institutional platforms trying to keep traders inside a single screen from analysis to order entry. Finance Magnates said TradingView integrations are expanding as platforms compete on workflow and access.

B2PRIME is pitching reach as much as tech. The firm said TradingView serves more than 100 million users and supports custom indicators built with Pine Script, TradingView’s scripting language.

The integration allows users to switch between B2TRADER accounts via the Trading Panel, B2PRIME said, and to trade from charts while using tools such as RSI and Bollinger Bands indicators. Alex Tsepaev, the group’s chief strategy officer, said the setup “can give traders a simpler, more efficient way to access liquidity.” markets.businessinsider.com

TradingView uses platinum, gold and silver broker badges to mark official broker accounts, with platinum shown as a blue BROKER badge, according to its help pages.

For B2PRIME, the upside is straightforward: fewer steps between a chart and a trade can mean more orders routed through its pipes. That does not guarantee stickier clients, but it lowers the excuse count.

But integrations can turn into a blame game when markets get busy. If the login flow drags, charts lag, or account checks slow new users, traders can shift to another broker in the same panel with little friction.

Stock Market Today

  • Wall Street Gains on AI Stock Rally Amid Inflation and Middle East Tensions
    June 11, 2026, 11:16 AM EDT. Wall Street recovered some weekly losses Thursday as artificial intelligence (AI) stocks rebounded, led by chipmakers like Marvell Technology (+5.5%), Intel (+7.8%), and Applied Materials (+7.5%). The S&P 500 rose 0.5%, Dow Jones 0.7%, and Nasdaq 0.7%. Despite market gains, concerns about elevated AI valuations persist, while Oracle shares fell 11.1% after revealing plans to raise $40 billion to fund AI investments. Oil prices remained steady despite rising tensions in the Iran conflict, with Brent crude at $92.64 and U.S. crude at $90.29 per barrel. Meanwhile, wholesale inflation in the U.S. exceeded expectations in May, prompting the European Central Bank to raise interest rates, signaling global inflationary pressures.

Latest articles

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

11 June 2026
TOVX soared 74.6% to $0.4252 after Theriva Biologics published Phase 1 VCN-01 data showing survival and biomarker signals in head-and-neck cancer, but the jump was not due to drug approval or revenue; investors face ongoing financing, dilution, and clinical-trial execution risks, with the company’s cash runway only into Q1 2027 and substantial doubt about its ability to continue as a going concern without new capital.
Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

11 June 2026
Trulieve began NYSE trading as TRLV this week after moving from OTC/CSE, authorized a buyback of up to $50 million or 8.5 million shares, and closed its first NYSE session at $11.50, down 0.43%, before trading near $11.78 early Thursday, as investors weigh whether the uplisting and buyback will boost demand amid ongoing federal cannabis policy uncertainty.
Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

11 June 2026
Propanc Biopharma shares soared as much as 392% after authorizing up to $5 million in stock buybacks—exceeding its prior $3.1 million equity value—even as it reported just $443,702 in cash and flagged going-concern risks, with investors now focused on whether its lead cancer drug PRP will advance to a planned Phase 1b trial this year.
EV Stocks Mixed in Premarket: Rivian Rises Despite Recall as Tesla, Lucid Slip
Previous Story

EV Stocks Mixed in Premarket: Rivian Rises Despite Recall as Tesla, Lucid Slip

Broadcom stock (AVGO) slides as Nvidia’s China chip payment demand ripples through AI semiconductors
Next Story

Broadcom stock (AVGO) slides as Nvidia’s China chip payment demand ripples through AI semiconductors

Go toTop